Document Detail


Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
MedLine Citation:
PMID:  21929546     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background  Clinical response to thiopurine medication is related to the concentration of its metabolites. Proxy measures are traditionally used to assess dose adequacy. We present our experience of using tioguanine (previously known/formerly referred to as thioguanine) metabolite measurements in paediatric patients and evaluate their effect on clinical practice. Aims  To report our experience of using tioguanine metabolite measurements in paediatric patients and to evaluate their effects on clinical practice. Methods  The 6-tioguanine nucleotide (6-TGN) and 6-methylmercaptopurine (6-MMP) were measured in children prescribed thiopurine medication for at least 3 months. Data were collected on thiopurine methyl transferase (TPMT) genotype, drug dose, laboratory indices and management changes. Therapeutic 6-TGN levels were defined as 235-400 pmol/8 × 10(8) RBCs. Seventy individuals (30 males) with a median age of 15 years. Underlying diagnoses were 'IBD' (68/70) and two cases of eosinophilic colitis. Sixty-three were treated with azathioprine and seven with mercaptopurine. A total of 103 separate measurements were made. Results  On initial measurement, 68% of patients had 6-TGN levels outside therapeutic levels despite standard thiopurine dosing. Initial 6-TGN levels were significantly higher in patients with TPMT mutations. Toxicity occurred in seven cases. The 6-TGN levels were significantly higher in those with signs of marrow toxicity. The 6-TGN level correlated with WBC, leukocyte count, mean corpuscular volume (MCV) and ΔMCV; however, the ability of each of these to predict therapeutic 6-TGN levels was poor. After initial measurement, management was changed in 25/70 cases (36%). Conclusions  6-TGN levels were therapeutic in a minority of those patients who were tested. Proxy measures perform poorly in predicting therapeutic 6-TGN levels. Measuring thiopurine metabolites is useful for dosage adjustment in children, and for the detection of potential toxicity.
Authors:
L Armstrong; J-A Sharif; P Galloway; P McGrogan; J Bishop; R K Russell
Related Documents :
1635106 - The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to...
8547046 - Topical isotretinoin in darier's disease.
20594756 - Reduction of cd47 on monocytes correlates with mods in burn patients.
24241366 - Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of...
3291086 - Suppression of emotions in essential dyspepsia and chronic duodenal ulcer. a case-contr...
8147706 - Blood levels of leukotrienes (ltc4, d4, e4, b4) in asthmatic patients during attack and...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-19
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  -     ISSN:  1365-2036     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 Blackwell Publishing Ltd.
Affiliation:
Department of Gastroenterology, Hepatology and Nutrition, Royal Hospital for Sick Children, Dalnair Street, Glasgow, UK. Department of Biochemistry, Royal Hospital for Sick Children, Dalnair Street, Glasgow, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High-throughput resequencing of target-captured cDNAs in cancer cells.
Next Document:  Quantitative relationships between occupant satisfaction and satisfaction aspects of indoor environm...